InChI=1S/C22H32O5/c1- 2- 3- 11- 14- 19(23) 15- 12- 9- 7- 5- 4- 6- 8- 10- 13- 16- 20(24) 21(25) 17- 18- 22(26) 27/h3- 4,6- 13,15- 16,19- 21,23- 25H,2,5,14,17- 18H2,1H3,(H,26,27) /b6- 4- ,9- 7- ,10- 8+,11- 3- ,15- 12+,16- 13+/t19- ,20+,21- /m0/s1 |
YKPLJNOOLKUEBS-RIYRYSNMSA-N |
C(C(O)=O)C[C@@H]([C@@H](/C=C/C=C/C=C\C/C=C\C=C\[C@H](C/C=C\CC)O)O)O |
|
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
|
|
human xenobiotic metabolite
Any human metabolite produced by metabolism of a xenobiotic compound in humans.
specialised pro-resolving mediator
A class of cell signaling molecules enzymatically derived from n-3 long chain polyunsaturated fatty acids that have important roles in orchestrating the resolution of tissue inflammation.
(via resolvin )
|
|
anti-inflammatory agent
Any compound that has anti-inflammatory effects.
specialised pro-resolving mediator
A class of cell signaling molecules enzymatically derived from n-3 long chain polyunsaturated fatty acids that have important roles in orchestrating the resolution of tissue inflammation.
(via resolvin )
|
|
View more via ChEBI Ontology
(4S,5R,6E,8E,10Z,13Z,15E,17S,19Z)- 4,5,17- trihydroxydocosa- 6,8,10,13,15,19- hexaenoic acid
|
(4S,5R,6E,8E,10Z,13Z,15E,17S,19Z)- 4,5,17- trihydroxydocosahexaenoic acid
|
ChEBI
|
RvD4
|
SUBMITTER
|
15726828
|
PubMed citation
|
Europe PMC
|
16799203
|
PubMed citation
|
Europe PMC
|
21418190
|
PubMed citation
|
Europe PMC
|
26462421
|
PubMed citation
|
Europe PMC
|
26743932
|
PubMed citation
|
Europe PMC
|
27534559
|
PubMed citation
|
Europe PMC
|
27734186
|
PubMed citation
|
Europe PMC
|
28765512
|
PubMed citation
|
Europe PMC
|
|